Federal regulators want more details from Chiron about operations at its plant that makes flu vaccine.
The Emeryville-based biotech company says it has received a warning letter from the Food and Drug Administration in connection with the agency´s inspection of its plant in Liverpool, England in October.
This post was last modified on 01/31/2009 4:41 pm